Abstract
Patient navigation represents a promising means to address racial, ethnic, and socioeconomic disparities in cancer-related outcomes. The Patient Navigation Research Program sponsored by the National Cancer Institute and the American Cancer Society was designed to assess the impact of patient navigation on patient outcomes. Patients with breast, cervical, colorectal, or prostate cancer screening abnormalities and/or diagnosed cancer from nine sites across the country were assigned to patient navigators or to usual care. A trained patient navigator met with assigned patients, collaboratively assessed patient barriers to cancer-related care and sought to address patient barriers. Using a validated measure of patient satisfaction with cancer related care, this presentation compares scores from navigated and un-navigated patients and discusses implications of these findings.
Citation Information: Cancer Epidemiol Biomarkers Prev 2011;20(10 Suppl):PL06-04.
RSS Feeds